Sharp-Header

Sharp-Header

X

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Reset Filter

All Drugs in Dev.

Product Type

Companies

Akouos

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

Food & Nutrition Conference & Expo

Participation Not Confirmed

Update your Virtual Booth

Akouos Closes $105 Million Series B Financing

Lead Product(s): AK-OTOF

Therapeutic Area: Otolaryngology (Ear, Nose, Throat) Product Name: Undisclosed

Highest Development Status: IND Enabling Product Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Pivotal bioVenture Partners

Deal Size: $105.0 million Upfront Cash: Undisclosed

Deal Type: Series B Financing March 03, 2020

Details:

Proceeds will be used to advance Akouos’s lead program, AK-OTOF, to first-in-human clin